Advanced search
Start date

Evaluation of the use of combination therapy in Crohns Disease

Grant number: 15/03101-8
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): May 01, 2015
Effective date (End): April 30, 2016
Field of knowledge:Health Sciences - Medicine - Surgery
Principal researcher:Claudio Saddy Rodrigues Coy
Grantee:Juliana Mazzuia Guimarães
Home Institution: Faculdade de Ciências Médicas (FCM). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil


Crohn's Disease (CD), is considered chronic condition originating from immune disorder and with difficult clinical remission. Despite therapeutic advances it evolves frequent activity episodes leading to complications and surgical treatment. At the present it is now considered that the use of combination therapy (anti TNF alpha antibody and azathioprine) is one of the best treatment option in patients with CD. Objective: To evaluate the results of the use of combination therapy in patients with CD. Material and Methods: longitudinal and observational studies based on records of patients of both sexes coming from "Inflammatory Diseases Ambulatory".- Gastrocentro" UNICAMP. Variables analyzed: sex, age, a Montreal classification, Crohn's Disease Activity Index (CDAI), time use factors related to the discontinuation of combination therapy (treatment failure, defined as CDAI over 150 adverse effects and lack compliance) consequently the occurrence of surgery.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items